Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01833 PA GOODDOCTOR
RTNominal unchange10.460 0.000 (0.000%)
Others

21/01/2020 18:01

{I-bank focus}Macquarie lifts PA GoodDoctor (01833) to HK$78

[ET Net News Agency, 21 January 2020] Macquarie Research raised its target price for
Ping An Healthcare and Technology (PAGD)(01833) to HK$78 from HK$65 and maintained its
"outperform" rating.
The research house said PAGD will release its 2019 annual results on 11 February 2020.
Macquarie estimated 41% revenue (excluding Corporate purchase) growth in 2H 2019. If
including the corporate purchases, it sees 18% revenue growth due to the high base of
corporate purchases in health mall in 2H 2018.
With leverage on expenses, Macquarie forecast PAGD to be on the trajectory to reach the
net margin breakeven in 2021. It raised its EPS forecast to Rmb-0.65/-0.33/0.12 from
-0.74/-0.45/0.01 in 2019/20/21. (KL)

Back to Others

Remark: Real time quote last updated: 24/04/2024 12:51
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.